Addus HomeCare Corporation $ADUS Position Increased by SG Americas Securities LLC

SG Americas Securities LLC boosted its stake in shares of Addus HomeCare Corporation (NASDAQ:ADUS) by 176.0% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 27,303 shares of the company’s stock after purchasing an additional 17,411 shares during the quarter. SG Americas Securities LLC’s holdings in Addus HomeCare were worth $2,557,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Capital Research Global Investors increased its position in Addus HomeCare by 22.3% in the fourth quarter. Capital Research Global Investors now owns 1,469,752 shares of the company’s stock worth $157,837,000 after buying an additional 268,192 shares during the period. Freestone Grove Partners LP grew its position in Addus HomeCare by 5,035.2% in the 4th quarter. Freestone Grove Partners LP now owns 137,932 shares of the company’s stock worth $14,813,000 after purchasing an additional 135,246 shares during the last quarter. 8 Knots Management LLC bought a new position in Addus HomeCare in the 3rd quarter worth about $6,075,000. Empowered Funds LLC increased its stake in shares of Addus HomeCare by 186.1% in the fourth quarter. Empowered Funds LLC now owns 70,927 shares of the company’s stock valued at $7,617,000 after purchasing an additional 46,137 shares during the period. Finally, Adage Capital Partners GP L.L.C. bought a new stake in shares of Addus HomeCare during the second quarter valued at approximately $4,838,000. 95.35% of the stock is currently owned by institutional investors.

Addus HomeCare Price Performance

NASDAQ ADUS opened at $100.47 on Wednesday. Addus HomeCare Corporation has a 12 month low of $87.95 and a 12 month high of $124.43. The firm has a market capitalization of $1.88 billion, a PE ratio of 18.57, a P/E/G ratio of 1.34 and a beta of 0.89. The company’s 50 day simple moving average is $94.45 and its 200 day simple moving average is $101.43. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.83 and a quick ratio of 1.83.

Addus HomeCare (NASDAQ:ADUS) last released its earnings results on Monday, May 4th. The company reported $1.62 earnings per share for the quarter, topping analysts’ consensus estimates of $1.52 by $0.10. The firm had revenue of $363.50 million during the quarter, compared to the consensus estimate of $366.41 million. Addus HomeCare had a return on equity of 9.80% and a net margin of 6.89%.The firm’s revenue for the quarter was up 7.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.42 earnings per share. As a group, equities research analysts forecast that Addus HomeCare Corporation will post 6.24 EPS for the current fiscal year.

Insider Activity at Addus HomeCare

In other news, insider Heather Brianne Dixon sold 288 shares of the business’s stock in a transaction on Monday, June 22nd. The stock was sold at an average price of $93.77, for a total value of $27,005.76. Following the sale, the insider owned 44,371 shares of the company’s stock, valued at approximately $4,160,668.67. The trade was a 0.64% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 966 shares of company stock valued at $90,168. 4.10% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. Citizens Jmp reiterated a “market outperform” rating and set a $142.00 price objective on shares of Addus HomeCare in a research report on Monday, May 18th. Weiss Ratings lowered Addus HomeCare from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday, May 22nd. Wall Street Zen cut Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, March 21st. Finally, Barclays lowered their price target on Addus HomeCare from $102.00 to $92.00 and set an “underweight” rating on the stock in a report on Friday, May 15th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $131.00.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.